About Polifarma
Polifarma is a company based in Rome (Italy) founded in 1919. It operates as a Direct-to-Consumer (D2C) and Professional Services. Polifarma has completed 1 acquisition, including HENNIG ARZNEIMITTEL. Polifarma offers products and services including Central Nervous System Treatments, Gastroenterology Products, Ophthalmology Solutions, Cardiovascular Medications, and Infectious Disease Treatments. Polifarma operates in a competitive market with competitors including AmerisourceBergen, Admenta Italia, LaNova Farmaceutici, Velit Biopharma and FL Group, among others.
- Headquarter Rome, Italy
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Polifarma Spa
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Polifarma
Polifarma offers a comprehensive portfolio of products and services, including Central Nervous System Treatments, Gastroenterology Products, Ophthalmology Solutions, Cardiovascular Medications, and Infectious Disease Treatments.
Treatments for common central nervous system diseases are provided.
Various products for gastrointestinal treatment are offered by Polifarma.
Ophthalmic treatments are developed through strategic market agreements.
Cardiovascular drugs are established for significant market presence.
Antibiotics and supplements for immune support are provided.
Funding Insights of Polifarma
Detailed funding history for Polifarma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Polifarma
Polifarma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include HENNIG ARZNEIMITTEL.
Investment portfolio details for Polifarma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Generic drugs are manufactured and supplied by Hennig Arzneimittel.
|
Locked | Locked | 1898 | Locked |
Complete acquisition details for Polifarma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Polifarma
Detailed financials for Polifarma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Polifarma Comparisons
Peer comparison for Polifarma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Polifarma
Polifarma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Admenta Italia, LaNova Farmaceutici, Velit Biopharma and FL Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| Locked | Locked | Locked |
Provides wholesale pharmaceutical sales, retail pharmacies, and industry services in Italy.
|
|
| Locked | Locked | Locked |
Company specializes in sales, promotion, and distribution of drugs, medical devices, supplements, and cosmetics
|
|
| Locked | Locked | Locked |
Pharmaceutical company that specializes in the development, distributing, and manufacturing of bio and nano pharmaceuticals, medical devices, and food supplements
|
|
| Locked | Locked | Locked |
Cannabis raw materials services are provided by FL Group.
|
|
| Locked | Locked | Locked |
Italian company specializing in cardiology pharmaceuticals and clinical nutrition products.
|
Detailed competitors of Polifarma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Polifarma
Complete news archive for Polifarma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Polifarma
Polifarma was founded in 1919.
Polifarma is headquartered in Rome, Italy. It is registered at Rome, Lazio, Italy.
Polifarma S.p.A. is focused on the development and distribution of pharmaceutical products across various therapeutic areas. Key sectors include central nervous system, gastroenterology, ophthalmology, cardiovascular, and infectious diseases. Solutions are tailored for healthcare professionals and aim to improve quality of life through innovative medicines and research. The company is recognized for its continuous growth and commitment to future-oriented medical advancements.
Polifarma's top competitors include AmerisourceBergen, FL Group and Velit Biopharma.
Polifarma offers Central Nervous System Treatments, Gastroenterology Products, Ophthalmology Solutions, Cardiovascular Medications, and Infectious Disease Treatments.
Polifarma has made 1 acquisition, including HENNIG ARZNEIMITTEL.